Sci-tech

Latest Short Interest in Valeant Pharmaceuticals Intl Inc (VRX) Increases By 10.5%

Latest Short Interest in Valeant Pharmaceuticals Intl Inc (VRX) Increases By 10.5%”

The firm now has a $18.00 price target on the specialty pharmaceutical company's stock. The stock presently has a consensus rating of Hold and an average target price of $17.71.

A number of other equities research analysts also recently weighed in on the company. Canaccord Genuity maintained the shares of VRX in report on Tuesday, October 3 with "Hold" rating. The specialty pharmaceutical company reported $1.05 earnings per share for the quarter, beating analysts' consensus estimates of $0.97 by $0.08. The count of Hold ratings in that period was 13. Piper Jaffray Companies reaffirmed a "sell" rating and set a $14.00 price objective on shares of Valeant Pharmaceuticals International in a report on Sunday, September 17th.

Analyst's mean target price for DEPO is $10.5 while analysts mean suggestion is 3. As per Friday, October 2, the company rating was downgraded by Morgan Stanley. (VRX), its current distance from 20-Day Simple Moving Average is -2.61% and standing -2.54% away from 50-Day Simple Moving Average while traded up 1.19% from 200-Day Simple Moving Average. Valeant Pharmaceuticals International has a 12 month low of $8.31 and a 12 month high of $24.30. The company has a 50-day moving average of $14.00 and a 200-day moving average of $13.52. The company's market capitalization is $4.46 billion.

More news: Shakespeare confirms Adrien Silva training with Leicester

Valeant Pharmaceuticals International (NYSE:VRX) (TSE:VRX) last issued its quarterly earnings data on Tuesday, August 8th. Following the completion of the transaction, the director now owns 77,479 shares in the company, valued at approximately $1,110,274.07. The company had revenue of $2.23 billion for the quarter, compared to analysts' expectations of $2.23 billion. Valeant Pharmaceuticals Intl had a negative net margin of 22.17% and a positive return on equity of 43.81%. The Capstone Investment Advisors Llc holds 46,800 shares with $808,000 value, up from 25,000 last quarter. Cambridge Investment Advsrs invested in 39,866 shares or 0.01% of the stock. If you are accessing this story on another publication, it was copied illegally and reposted in violation of United States and worldwide copyright and trademark legislation. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has declined 48.51% since October 12, 2016 and is downtrending. 20,000 shares were bought by DE SCHUTTER RICHARD U, worth $278,000 on Thursday, May 11. Moving averages are considered to be lagging indicators that simply take the average price of a stock over a certain period of time. Saba Capital Management L.P. now owns 2,315,900 shares of the specialty pharmaceutical company's stock valued at $25,544,000 after acquiring an additional 1,319,311 shares during the period. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The stock remained 6.12% unpredictable for the week and 5.31% for the month. Gulf International Bank UK Ltd raised its stake in shares of Valeant Pharmaceuticals Intl by 1.1% in the first quarter. It worsened, as 53 investors sold Valeant Pharmaceuticals Intl Inc shares while 76 reduced holdings. World Asset Management Inc raised its stake in shares of Valeant Pharmaceuticals Intl by 1.5% in the first quarter. The stock of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) earned "Sector Perform" rating by RBC Capital Markets on Friday, May 5. Renaissance Technologies LLC acquired a new position in shares of Valeant Pharmaceuticals International in the 2nd quarter valued at $41,574,000. Canada Pension Plan Board invested in 2.10 million shares. The last close places the company's stock about $2.67 off its 52 week high of $28.51 and $5.71 above the 52 week low of $20.13. Finally, Cannell Peter B & Co.

Valeant Pharmaceuticals Internat (NYSE:VRX) had an increase of 0.65% in short interest.

In analysts report sent to investors on 12 October, Mondi PLC (LON:MNDI) stock Neutral was restate by Analysts at Citigroup. Valeant Pharmaceuticals Intl had 132 analyst reports since July 21, 2015 according to SRatingsIntel.



Like this

loading...
loading...

Latest


13 October 2017
Militant arrested in Tral, south Kashmir
"He was involved in a grenade attack at bus stand Tral in Pulwama on December 5, 2014 in which five people were killed". A case FIR number 121/2014 under section 307/RPC, 2/5 Exp.

13 October 2017
Prince Harry accepts Legacy Award on behalf of the late Princess Diana
Also pictured inside: Harry in a tux at the 100 Women in Finance Gala Dinner on Wednesday night. In front of the world's media, she shook the hand of a man suffering with the illness.

13 October 2017
Ex-Dividend Reminder: Graham Holdings, Saul Centers and PNC Financial Services Group
Following the completion of the transaction, the insider now owns 23,820 shares of the company's stock, valued at $3,058,488. Charter Equity downgraded Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) on Wednesday, July 20 to "Mkt Underperform" rating.

13 October 2017
Madhya Pradesh govt cuts Value-Added Tax on petrol and diesel
Earlier, the central government had reduced the excise duty on petrol and diesel rates by Rs 2 per litre each. Later in the evening Himachal Pradesh, ruled by Congress, announced a 1% reduction in Value-Added Tax .

13 October 2017
Netflix up after price target increase to new Street high
Following the transaction, the insider now directly owns 2,135 shares of the company's stock, valued at approximately $312,756.15. A number of other hedge funds and other institutional investors have also recently modified their holdings of NFLX .

13 October 2017
TD Ameritrade Holding Corp's (NYSE:AMTD) Sentiment is 1.05
Also, it has an estimated price-earnings (P/E) multiple of 19.66 and a trailing 12-month price-earnings (P/E) multiple of 24.76. Recent trading patterns in the stock of TD Ameritrade Holding Corporation (NASDAQ: AMTD ) have investors on high alert.

13 October 2017
Despite record profit, Samsung CEO plans to quit
"With a new spirit and young leadership to better respond to challenges arising from the rapidly changing IT industry", he added. Kwon also said he won't seek reelection as a member of the company's board of directors once his term ends in March.

13 October 2017
Brokers Opinions on: Flexion Therapeutics, Inc. (FLXN)
News articles about Flexion Therapeutics (NASDAQ: FLXN ) have been trending somewhat positive this week, Alpha One reports. ValuEngine upgraded Flexion Therapeutics from a sell rating to a hold rating in a research note on Friday, September 1st.

13 October 2017
Simeone: Messi was everything Argentina fans wanted
While Sampaoli was delighted with his captain's performance, he said the side had to stop relying on him so much. Let us know in the comments section below.

13 October 2017
Chris Hughton says Ronald Koeman big enough to handle Everton pressure
Dick Advocaat left the Netherlands post after they failed to qualify for the 2018 Russia World Cup and the pool of individually talented players are now rudderless.